Publications
- G-CSF plus azacitidine versus azacitidine alone for patients with high-risk myelodysplastic syndrome: academic, open label, randomized trial2022 | Faculty of Mathematics and Physics, First Faculty of Medicine
- Analysis of 5-Azacytidine Resistance Models Reveals a Set of Targetable Pathways2022 | First Faculty of Medicine
- Hereditary Haemorrhagic Telangiectasia (HHT) Marked by ACVRL1(C1120T) Variant Displays Hypopigmented Naevi and Frequent Bleeding Episodes if CYP2C9 Co-Mutated: Clinical Notes & Rationale of Patient Registry2020 | First Faculty of Medicine
- Randomizovaná otevřená akademická studie: srovnání standardního pod ání azacytidinu oproti azacytidinu s preinkubací G-CSF u myelodysplastického syndromu vyššího rizika - interim analýza2019 | Faculty of Mathematics and Physics, First Faculty of Medicine, Faculty of Physical Education and Sport
- MiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemia2017 | Faculty of Mathematics and Physics, First Faculty of Medicine
- Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas2017 | Faculty of Mathematics and Physics, First Faculty of Medicine
- Somatic mutation dynamics in MDS patients treated with azacitidine indicate clonal selection in patients-responders2017 | Faculty of Mathematics and Physics, First Faculty of Medicine
- Differential expression, localization and activity of MARCKS between mantle cell lymphoma and chronic lymphocytic leukemia2016 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Oncogenic microRNA-155 and its target PU.1: an integrative gene expression study in six of the most prevalent lymphomas2015 | First Faculty of Medicine
- Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum2014 | Faculty of Mathematics and Physics, First Faculty of Medicine
Loading network view...